NCT00120588View on ClinicalTrials.gov

Neuroprotection by Magnesium Sulfate Given to Women at Risk of Very Preterm Birth

PHASE4CompletedINTERVENTIONAL
Enrollment

700

Participants

Timeline

Start Date

July 31, 1997

Study Completion Date

July 31, 2005

Conditions
Preterm BirthPeriventricular LeukomalaciaBrain IschemiaIntracranial Hemorrhages
Interventions
DRUG

magnesium

Trial Locations (1)

76031

Charles-Nicolle hospital, Rouen

All Listed Sponsors
collaborator

Ministry of Health, France

OTHER_GOV

lead

University Hospital, Rouen

OTHER

NCT00120588 - Neuroprotection by Magnesium Sulfate Given to Women at Risk of Very Preterm Birth | Biotech Hunter | Biotech Hunter